tiprankstipranks
Penumbra (PEN)
NYSE:PEN
US Market
PEN
Penumbra
RESEARCH TOOLSreports

Penumbra (PEN) Stock News & Sentiment

Compare
475 Followers
Hold Rating Maintained on Penumbra Amid Strong Results but Limited Visibility Ahead of Boston Scientific Acquisition
Premium
Ratings
Hold Rating Maintained on Penumbra Amid Strong Results but Limited Visibility Ahead of Boston Scientific Acquisition
27d ago
PEN
Is PEN a Buy, Before Earnings?
Premium
Pre-Earnings
Is PEN a Buy, Before Earnings?
1M ago
PEN
Penumbra’s Indigo Post‑Market Study in Japan Reaches Completion, Setting the Stage for New Real‑World Data
Premium
Company Announcements
Penumbra’s Indigo Post‑Market Study in Japan Reaches Completion, Setting the Stage for New Real‑World Data
2M ago
PEN
Penumbra: Rating Cut to Hold as Boston Scientific Takeout Caps Upside at $374 Deal Price
Premium
Ratings
Penumbra: Rating Cut to Hold as Boston Scientific Takeout Caps Upside at $374 Deal Price
2M ago
PEN
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
2M ago
C
GS
M&A News: Penumbra Stock (PEN) Beats Harder on $14.5B Boston Scientific (BSX) Acquisition
Premium
Market News
M&A News: Penumbra Stock (PEN) Beats Harder on $14.5B Boston Scientific (BSX) Acquisition
2M ago
BSX
PEN
Penumbra Announces Strong Preliminary Revenue Growth for 2025
Premium
Company Announcements
Penumbra Announces Strong Preliminary Revenue Growth for 2025
2M ago
8K
PEN
More PEN News >

PEN News on the Web

Private Markets: Kraken pauses IPO plans, Quince raises $500M
TipRanks News
Neutral
Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"
Zacks
Bullish
Insider Sell: Maggie Yuen Sells Shares of Penumbra Inc (PEN)
GuruFocus News
Bearish
PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise
Zacks
Bullish
RBC Capital Sticks to Its Hold Rating for Penumbra (PEN)
TipRanks News
Neutral
Compared to Estimates, Penumbra (PEN) Q4 Earnings: A Look at Key Metrics
Zacks
Bullish
Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates
Zacks
Bullish
Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX) and Penumbra (PEN)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
PEN
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PEN’s Media Buzz Sentiment?
1 articles about PEN were published this week. In an average week, 3.25 articles are published.
    What is PEN’s weekly average amount of articles?
    In an average week, 3.25 articles about PEN are published.
      What is PEN’s News Sentiment?
      50% of articles about PEN were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        HYPRHyperfine
        OVIDOvid Therapeutics
        INNMFAmplia Therapeutics
        ALMSAlumis Inc.
        NWPHFNewron Pharmaceuticals SpA
        Showing the stocks with the most bullish news sentiment over the past week